EP Patent

EP1725234B9 — Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects

Assigned to University of Pennsylvania Penn · Expires 2013-04-10 · 13y expired

What this patent protects

Patent listed against lomitapide-mesylate.

Drugs covered by this patent

lomitapide-mesylate (LOMITAPIDE MESYLATE)

Patent Metadata

Patent number: EP1725234B9
Jurisdiction: EP
Classification: —
Expires: 2013-04-10
Drug substance claim: No
Drug product claim: No
Assignee: University of Pennsylvania Penn
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.